Sensitive methods to define subtle memory decline capture intra‐individual hippocampal atrophy and increased cortical volumes in preclinical Alzheimer’s

Episodic memory obj-SCD captured longitudinal changes in GMv indicative of AD-progression (i.e., hippocampus). These results suggested that episodic memory obj-SCD is a consistent marker of AD-related impairment. Characterizing obj-SCD enhances preclinical stage identification, with implications for advancing early detection and intervention strategies in Alzheimer's disease, informing about an elevated risk of AD-dementia in an otherwise CU population.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.085873
Citations
1
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sensitive methods to define subtle memory decline capture intra‐individual hippocampal atrophy and increased cortical volumes in preclinical Alzheimer’s

Marta Milà‐Alomà, Gonzalo Sánchez‐Benavides, Raffaele Cacciaglia, Juan Domingo Gispert et al.
1 citations
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
0.39
article

Sensitive methods to define subtle memory decline capture intra‐individual hippocampal atrophy and increased cortical volumes in preclinical Alzheimer’s

Marta Milà‐Alomà, Gonzalo Sánchez‐Benavides, Raffaele Cacciaglia, Juan Domingo Gispert, Oriol Grau‐Rivera, Henrik Zetterberg, Marc Suárez‐Calvet, Carolina Minguillón, David López‐Martos, Kaj Blennow
article en
1 citations

Abstract

Episodic memory obj-SCD captured longitudinal changes in GMv indicative of AD-progression (i.e., hippocampus). These results suggested that episodic memory obj-SCD is a consistent marker of AD-related impairment. Characterizing obj-SCD enhances preclinical stage identification, with implications for advancing early detection and intervention strategies in Alzheimer's disease, informing about an elevated risk of AD-dementia in an otherwise CU population.

Alzheimer s & DementiaVol. 20(S3)
University of Wisconsin–Madison (US), University of California, San Francisco (US), Sahlgrenska University Hospital (SE), Instituto de Salud Carlos III (ES), Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES), Pasqual Maragall Foundation (ES), Barcelonaβeta Brain Research Center (ES), Hospital Del Mar (ES), Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (ES), National Hospital for Neurology and Neurosurgery (GB), Hospital del Mar Research Institute (ES), Northern California Institute for Research and Education (US), University College London (GB), University of Gothenburg (SE)
Openalex Percentile: Top 32%
Dementia and Cognitive Impairment Research
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.